drugset / Trial / NCT01256294
Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients
RandomizedCrossoverOpen-labelTreatment
Summary
The study is designed to compare the pharmacokinetics of generic tacrolimus (Sandoz) to branded tacrolimus (Prograf) in stable renal transplant patients.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.5 mg | Oral |
| Subject | Tacrolimus | Small molecule | 1 mg | Oral |
| Subject | Tacrolimus | Small molecule | 5 mg | Oral |
Indications
No indication recorded.